Can Robaxin (methocarbamol) be taken with Keppra (levetiracetam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Robaxin (Methocarbamol) Be Taken with Keppra (Levetiracetam)?

Yes, Robaxin (methocarbamol) can be safely taken with Keppra (levetiracetam) as there are no significant drug interactions between these medications, though patients should be monitored for additive sedative effects.

Drug Interaction Profile

Levetiracetam has a highly favorable drug interaction profile that makes it compatible with most medications:

  • Levetiracetam has minimal effects on the cytochrome P450 enzyme system, resulting in significantly fewer drug-drug interactions compared to older antiepileptic medications like carbamazepine, phenytoin, or valproate 1, 2.

  • Non-enzyme-inducing antiepileptic drugs like levetiracetam are specifically preferred to avoid interactions with other medications, chemotherapy, targeted therapies, and steroids 1.

  • The National Comprehensive Cancer Network specifically recommends levetiracetam because it does not have significant drug interactions, unlike phenytoin, phenobarbital, or carbamazepine 3.

Clinical Monitoring Considerations

While these medications can be taken together, there are important monitoring considerations:

  • Both methocarbamol (a muscle relaxant) and levetiracetam can cause sedation, so patients should be monitored for additive sedative effects including increased drowsiness or somnolence 3, 2.

  • Common side effects to watch for include dizziness, somnolence, or fatigue, which can occur with levetiracetam and might be additive when combined with other CNS depressants 2.

  • No dose adjustments are required solely because these medications are being used together 2.

Practical Recommendations

  • Start with standard doses of each medication as clinically indicated 3.

  • Adjust levetiracetam doses based on renal function if necessary, as this is the primary consideration for dosing rather than drug interactions 3.

  • Counsel patients about the potential for increased sedation and advise caution with activities requiring alertness, particularly when first starting the combination.

  • Unlike older antiepileptic drugs, levetiracetam does not require cardiac monitoring during administration and has fewer documented interactions with other medications 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safe Co-Prescription of Levetiracetam and Sertraline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Compatibility of Levetiracetam and Meclizine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Levetiracetam Loading Dose Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.